Perioperative Implications of Vascular Endothelial Dysfunction: Current Understanding of this Critical Sensor-Effector Organ

Current Anesthesiology Reports

Volumn 3, Issue 3, 2013, Pages 151-161

  Riedel, Bernhard ^a   Rafat, Neysan ^b   Browne, Kim ^a   Burbury, Kate ^a   Schier, Robert ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Bone marrow; Brachial artery reactivity testing; Endothelial progenitor cells (EPC); Endothelium; Exercise; Flow mediated dilation; FMD; Outcomes; Perioperative; Postoperative; Statins; Surgical

Indexed keywords

EID: 84891827210     PISSN: 21676275     EISSN: 15233855     Source Type: Journal    
DOI: 10.1007/s40140-013-0024-7     Document Type: Review

References (90)

1. Tousoulis D, Charakida M, Stefanadis C. Endothelial function and inflammation in coronary artery disease. Heart. 2006;92:441–4.
2. Cepinskas G, Wilson JX. Inflammatory response in microvascular endothelium in sepsis: role of oxidants. J Clin Biochem Nutr. 2008;42:175–84. DOI: 10.3164/jcbn.2008026
3. Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care. 2011;34(Suppl 2):S285–90. DOI: 10.2337/dc11-s239
4. Gokce N, Keaney JF, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002;105:1567–72. DOI: 10.1161/01.CIR.0000012543.55874.47
5. • Schier R, Hinkelbein J, Marcus H, et al. Preoperative microvascular dysfunction: a prospective, observational study expanding risk assessment strategies in major thoracic surgery. Ann Thorac Surg. 2012;94:226–33. This study highlights the role of improved perioperative risk stratification by testing for endothelial vasodilator function.
6. Bhagat K, Moss R, Collier J, Vallance P. Endothelial “stunning” following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res. 1996;32:822–9.
7. Davies PF. Endothelial mechanisms of flow-mediated athero-protection and susceptibility. Circ Res. 2007;101:10–2. DOI: 10.1161/CIRCRESAHA.107.156539
8. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7. DOI: 10.1126/science.275.5302.964
9. Hill JM, Zalos G, Halcox JPJ, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593–600. DOI: 10.1056/NEJMoa022287
10. Vogel RA. Eating, vascular biology, and atherosclerosis: a lot to chew on. Eur Heart J. 2006;27:13–4. DOI: 10.1093/eurheartj/ehi638
11. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90. DOI: 10.1056/NEJMoa1200303
12. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–906. DOI: 10.1161/01.CIR.101.16.1899
13. Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol. 2003;23:1245–9. DOI: 10.1161/01.ATV.0000078603.90302.4A
14. Clapp BR, Hingorani AD, Kharbanda RK, et al. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res. 2004;64:172–8. DOI: 10.1016/j.cardiores.2004.06.020
15. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 1997;96:3042–7. DOI: 10.1161/01.CIR.96.9.3042
16. Tonetti MS, D’Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356:911–20. DOI: 10.1056/NEJMoa063186
17. Farb MG, Tiwari S, Karki S, et al. Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. Obesity. 2013;. doi:10.1002/oby.20505.
18. •• Hu YJ, Wei AN, Chook P,. The impact of noncardiovascular surgery on reactive hyperaemia and arterial endothelial function. Clinical and experimental pharmacology & physiology. 2013. This study highlights the decline in endothelial vasodilator function during the postoperative period.
19. Chello M, Goffredo C, Patti G, et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Eur J Cardiothorac Surg. 2005;28:805–10. DOI: 10.1016/j.ejcts.2005.09.013
20. Biccard BM, Rodseth RN. The pathophysiology of peri-operative myocardial infarction. Anaesthesia. 2010;65:733–41. DOI: 10.1111/j.1365-2044.2010.06338.x
21. Kikura M, Oikawa F, Yamamoto K, et al. Myocardial infarction and cerebrovascular accident following non-cardiac surgery: differences in postoperative temporal distribution and risk factors. J Thromb Haemost. 2008;6:742–8. DOI: 10.1111/j.1538-7836.2008.02948.x
22. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997;349:1391–2. DOI: 10.1016/S0140-6736(96)09424-X
23. Schier R, Marcus HE, Mansur E, et al. Evaluation of digital thermal monitoring as a tool to assess perioperative vascular reactivity. J Atheroscler Thromb. 2013;20:277–86. DOI: 10.5551/jat.15255
24. Licker M, Spiliopoulos A, Frey JG, et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest. 2002;121:1890–7. DOI: 10.1378/chest.121.6.1890
25. Duque JL, Ramos G, Castrodeza J, et al. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica. Ann Thorac Surg. 1997;63:944–50. DOI: 10.1016/S0003-4975(97)00051-9
26. Riedel B, Schier R. Endothelial dysfunction in the perioperative setting. Semin Cardiothorac Vasc Anesth. 2010;14:41–3. DOI: 10.1177/1089253210362793
27. Gokce N. Clinical assessment of endothelial function: ready for prime time? Circ Cardiovasc Imaging. 2011;4:348–50. DOI: 10.1161/CIRCIMAGING.111.966218
28. Gokce N, Keaney J F Jr, Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41:1769–75. DOI: 10.1016/S0735-1097(03)00333-4
29. Schier R, Riedel B. Brachial artery reactivity testing for preoperative microvascular risk assessment in major thoracic surgery. Ann Thorac Surg. 2013;95:1140. DOI: 10.1016/j.athoracsur.2012.08.118
30. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology. 2006;105:1260–72 Quiz 89–90. DOI: 10.1097/00000542-200612000-00027
31. • Hughes CG, Morandi A, Girard TD, et al. Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology. 2013;118:631–9. This study provides early insight into a plausible link that may exist between critical illness and endothelial dysfunction, with contribution of alterations of cerebral blood flow and blood-brain barrier permeability to acute brain dysfunction of critical illness.
32. Jain NB, Guller U, Pietrobon R, Bond TK, Higgins LD. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res. 2005:232–8.
33. Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol. 2011;50:266–72. DOI: 10.1016/j.yjmcc.2010.07.009
34. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–5. DOI: 10.1016/0140-6736(92)93147-F
35. Gul KM, Ahmadi N, Wang Z, et al. Digital thermal monitoring of vascular function: a novel tool to improve cardiovascular risk assessment. Vasc Med. 2009;14:143–8. DOI: 10.1177/1358863X08098850
36. • Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126:753–67. A review of clinical applicability of assessing endothelial function.
37. Ahmadi N, Usman N, Shim J, et al. Vascular dysfunction measured by fingertip thermal monitoring is associated with the extent of myocardial perfusion defect. J Nucl Cardiol. 2009;16:431–9. DOI: 10.1007/s12350-008-9044-y
38. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117:2467–74. DOI: 10.1161/CIRCULATIONAHA.107.748574
39. Corretti M. Brachial artery reactivity: clinical tool or research toy? J Am Soc Echocardiogr. 2004;17:693–6. DOI: 10.1016/j.echo.2004.03.016
40. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–65. DOI: 10.1016/S0735-1097(01)01746-6
41. McQuilkin GL, Panthagani D, Metcalfe RW, et al. Digital thermal monitoring (DTM) of vascular reactivity closely correlates with Doppler flow velocity. Conf Proc IEEE Eng Med Biol Soc. 2009;1:1100–3.
42. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31:1142–8. DOI: 10.1093/eurheartj/ehq010
43. Bonetti PO, Pumper GM, Higano ST, Holmes D R Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44:2137–41. DOI: 10.1016/j.jacc.2004.08.062
44. Wright CI, Scholten HJ, Schilder JC, et al. Arterial stiffness, endothelial function and microcirculatory reactivity in healthy young males. Clin Physiol Funct Imaging. 2008;. doi:10.1111/j.1475-097X.2008.00807.x.
45. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med. 2005;172:854–60. DOI: 10.1164/rccm.200410-1325OC
46. Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM. Microparticles: biomarkers and beyond. Clin Sci. 2013;124:423–41. DOI: 10.1042/CS20120309
47. Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens. 2012;6:85–99. DOI: 10.1016/j.jash.2011.11.003
48. Rafat N, Hanusch C, Brinkkoetter PT, et al. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med. 2007;35:1677–84. DOI: 10.1097/01.CCM.0000269034.86817.59
49. •• Cao JP, He XY, Xu HT, Zou Z, Shi XY. Autologous transplantation of peripheral blood-derived circulating endothelial progenitor cells attenuates endotoxin-induced acute lung injury in rabbits by direct endothelial repair and indirect immunomodulation. Anesthesiology. 2012;116:1278–87. This study highlights the regenerative role of the bone marrow and potential for a future role for exogenous cellular therapy.
50. Rebound risk: aspirin and statin withdrawal. Consumer reports. 2005;70:48.
51. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301–7. DOI: 10.1056/NEJM199511163332001
52. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615–22. DOI: 10.1001/jama.279.20.1615
53. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med. 1996;335:1001–9. DOI: 10.1056/NEJM199610033351401
54. Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980–9. DOI: 10.1056/NEJMoa0808207
55. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848–51. DOI: 10.1161/01.CIR.0000066286.15621.98
56. Kertai MD, Boersma E, Westerhout CM, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 2004;28:343–52. DOI: 10.1016/j.ejvs.2004.07.008
57. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291:2092–9. DOI: 10.1001/jama.291.17.2092
58. •• Kuhn EW, Liakopoulos OJ, Stange S, et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg. 2013. This meta-analysis highlights the clinical role of perioperative statin therapy, which is mediated through pleiotropic effects that include improved endothelial function and anti-inflammatory effects.
59. Bonnet F, Samama CM. Cases of fraud in publications: from Darsee to Poldermans. Presse medicale. 2012;41:816–20. DOI: 10.1016/j.lpm.2012.04.019
60. Poldermans D. Scientific fraud or a rush to judgment? Am J Med. 2013;126:e5–6. DOI: 10.1016/j.amjmed.2012.10.018
61. Le Manach Y, Coriat P, Collard CD, Riedel B. Statin therapy within the perioperative period. Anesthesiology. 2008;108:1141–6. DOI: 10.1097/ALN.0b013e318173ef8e
62. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J. 2009;30:2769–812. DOI: 10.1093/eurheartj/ehp337
63. Qaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med. 2006;144:575–80. DOI: 10.7326/0003-4819-144-8-200604180-00008
64. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109:1801–9. DOI: 10.1182/blood-2006-08-043471
65. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood. 2005;105:2783–6. DOI: 10.1182/blood-2004-08-3057
66. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104:2752–60. DOI: 10.1182/blood-2004-04-1396
67. Ghani U, Shuaib A, Salam A, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke. 2005;36:151–3. DOI: 10.1161/01.STR.0000149944.15406.16
68. Rafat N, Beck G, Pena-Tapia PG, Schmiedek P, Vajkoczy P. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke. 2009;40:432–8. DOI: 10.1161/STROKEAHA.108.529420
69. Rafat N, Beck G, Schulte J, Tuettenberg J, Vajkoczy P. Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg. 2010;112:43–9. DOI: 10.3171/2009.5.JNS081074
70. Nowak K, Rafat N, Belle S, et al. Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease. Eur J Cardiothorac Surg. 2010;37:758–63. DOI: 10.1016/j.ejcts.2009.10.002
71. Voswinckel R, Ziegelhoeffer T, Heil M, et al. Circulating vascular progenitor cells do not contribute to compensatory lung growth. Circ Res. 2003;93:372–9. DOI: 10.1161/01.RES.0000087643.60150.C2
72. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–8.
73. Estes ML, Mund JA, Ingram DA, Case J. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Curr Protoc Cytom. 2010;Chapter 9:Unit 9 33 1–11.
74. Medina RJ, O’Neill CL, Sweeney M, et al. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics. 2010;3:18. DOI: 10.1186/1755-8794-3-18
75. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med. 2009;13:87–8102. DOI: 10.1111/j.1582-4934.2008.00598.x
76. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 2007;109:4761–8. DOI: 10.1182/blood-2006-12-062471
77. Yamada M, Kubo H, Ishizawa K, Kobayashi S, Shinkawa M, Sasaki H. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax. 2005;60:410–3. DOI: 10.1136/thx.2004.034058
78. Lam CF, Roan JN, Lee CH, et al. Transplantation of endothelial progenitor cells improves pulmonary endothelial function and gas exchange in rabbits with endotoxin-induced acute lung injury. Anesth Analg. 2011;112:620–7. DOI: 10.1213/ANE.0b013e3182075da4
79. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005;45:321–5. DOI: 10.1161/01.HYP.0000154789.28695.ea
80. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964–72. DOI: 10.1093/emboj/18.14.3964
81. Cesari F, Sofi F, Caporale R, et al. Relationship between exercise capacity, endothelial progenitor cells and cytochemokines in patients undergoing cardiac rehabilitation. Thromb Haemost. 2009;101:521–6.
82. Redondo S, Hristov M, Gordillo-Moscoso AA, Ruiz E, Weber C, Tejerina T. High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3− lymphocyte sub-population. J Immunol Methods. 2008;. doi:10.1016/j.jim.2008.02.011.
83. Laufs U, Urhausen A, Werner N, et al. Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil. 2005;12:407–14. DOI: 10.1097/01.hjr.0000174823.87269.2e
84. Sandri M, Adams V, Gielen S, et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation. 2005;111:3391–9. DOI: 10.1161/CIRCULATIONAHA.104.527135
85. Paul JD, Powell TM, Thompson M, et al. Endothelial progenitor cell mobilization and increased intravascular nitric oxide in patients undergoing cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2007;27:65–73.
86. Moyna NM, Thompson PD. The effect of physical activity on endothelial function in man. Acta Physiol Scand. 2004;180:113–23. DOI: 10.1111/j.0001-6772.2003.01253.x
87. Condon ET, Wang JH, Redmond HP. Surgical injury induces the mobilization of endothelial progenitor cells. Surgery. 2004;135:657–61. DOI: 10.1016/j.surg.2003.10.012
88. Becchi C, Pillozzi S, Fabbri LP, et al. The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. Int J Immunopathol Pharmacol. 2008;21:697–705.
89. Jeong JO, Kim MO, Kim H, et al. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation. 2009;119:699–708. DOI: 10.1161/CIRCULATIONAHA.108.789297
90. Rehman J, Li J, Parvathaneni L, et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol. 2004;43:2314–8. DOI: 10.1016/j.jacc.2004.02.049